BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem CellsGemma Molyneux, Matthew J. Smalley, Felipe C. Geyer et al.|Cell stem cell|2010Cited by 814
<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast CancerNicholas C. Turner, Alan Ashworth, Alex Pearson et al.|Cancer Research|2010Cited by 740
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targetsNicholas C. Turner, Jorge S. Reis‐Filho, Marc J. van de Vijver et al.|Oncogene|2010Cited by 416
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutationFelipe C. Geyer, Jorge S. Reis‐Filho, Magali Lacroix‐Triki et al.|Modern Pathology|2010Cited by 377
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomasFelipe C. Geyer, Jorge S. Reis‐Filho, Britta Weigelt et al.|The Journal of Pathology|2009Cited by 255